외국의 의약품 부작용 피해구제제도 현황과 국내 실시 방안
Social Relief Scheme for Serious Adverse Drug Reactions - Lessons from other countries for Korea
3
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
This study investigated social relief schemes for serious adverse drug reactions in foreign countries and deduced lessons and implications for Korea to implement the scheme. A social relief scheme for serious adverse drug reactions provides reliefs for diseases and such health effects as disabilities or deaths that were caused by adverse reactions to pharmaceuticals prescribed at hospitals and clinics as well as those purchased at pharmacies notwithstanding their proper use. The US and the UK do not have specific relief schemes for adverse drug reactions but apply rules of strict liability or negligence. New Zealand and Nordic countries provide no-fault compensation schemes for health effects or injuries caused by medical treatments or medicinal products. Japan and Taiwan have operated the schemes since 1980 and 2000, respectively. In designing the scheme in Korea, we suggested that cases eligible for relief be confined to serious adverse reactions such as death or disability and then extended to diseases. It is desirable to encourage the reporting system of adverse drug reactions and quality use of medicines for the relief scheme to work efficiently.
Abstract
This study investigated social relief schemes for serious adverse drug reactions in foreign countries and deduced lessons and implications for Korea to implement the scheme. A social relief scheme for serious adverse drug reactions provides reliefs for diseases and such health effects as disabilities or deaths that were caused by adverse reactions to pharmaceuticals prescribed at hospitals and clinics as well as those purchased at pharmacies notwithstanding their proper use. The US and the UK do not have specific relief schemes for adverse drug reactions but apply rules of strict liability or negligence. New Zealand and Nordic countries provide no-fault compensation schemes for health effects or injuries caused by medical treatments or medicinal products. Japan and Taiwan have operated the schemes since 1980 and 2000, respectively. In designing the scheme in Korea, we suggested that cases eligible for relief be confined to serious adverse reactions such as death or disability and then extended to diseases. It is desirable to encourage the reporting system of adverse drug reactions and quality use of medicines for the relief scheme to work efficiently.
참고문헌 (25)
- 박병주, "우리나라 약물안전성 관리체계 확립 방안", 대한약 물역학위해관리학회 심포지엄 (2007)
- Lazarow J, "Incidence of adverse drug reaction in hospitalized patients", JAMA, 279(15), pp.1200~1205 (1998)
- Pirmohamed M, "Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients", BMJ, 329, pp.15~19 (2004)
- Pouyanne P, "Admissions to hospital caused by adverse drug reactions: cross sectional incidence study", BMJ, 320, pp.1036~ (2000)
- 식품의약품안전청, "식품의약품통계연보", pp.261~ (2007), 식품의약품안전청
- 안명옥, "의약품 안전관리 선진화 방안. 2006 국정감사 정 책자료집 시리즈 #5", pp.3~20 (2006)
- 삼성방재연구소, "미국 PL 법률환경의 이해", pp.1~53 (2004), 삼성방재연구소
- Smith R, "Compensation for drug injury: problems both sides of the Atlantic", BMJ, 282(6274), pp.1443~1445 (1981)
- Smith R., "Compensation for drug injury: two solutions to an insoluble problem", BMJ, 282(6274), pp.1610~1612 (1981)
- No authors listed, "Compensation for drug injury", BMJ, 2(6205), pp.1674~1675 (1979)
- 삼성방재연구소, "EU PL 지침의 이해", 삼성방재연구소, 8, pp.1~52 (2004)
- 문옥륜, "의료사고 피해구제제도 개발에 관한 연구", 대한병원협회, pp.303~330 (1992), 대한의학협회
- Bismark M, "No-fault compensation in New Zealand: harmonizing injury compensation, provider accountability, and patient safety", Health Aff (Millwood), 25(1), pp.278~283 (2006)
- ACC, "Annual report 2006", pp.40~127 (2006), ACC
- Smith R, "Compensation for drug injury: two solutions to an insoluble problem", BMJ, 282(6274), pp.1610~1612 (1981)
- 의약품의료기기종합기구, "의약품 부작용 피해구제제도 Q&A", 의약품의료기기종합기구, 3, pp.1~19 (2007)
- Annual Report, "PMDA", PMDA, ~ (2005)
- 藥害救濟基金會, "九十巳年年報", pp.1~10 (2005), 藥害救濟基金會
- "藥害救濟法令解釋 第十三條", ~
- 의약품의료기기종합기구, "시판후안전대책에 관하여" (2007), 의약품의료기기종합기구
- 이의경, "의약품 안전확보를 위한 리스 크 관리방안", pp.2005, 한국보건사회연구원
- Institute of Medicine, "Preventing medication errors", pp.1~6 (2006), The National Academies Press
- 보건복지부, "보건복지백서", pp.41~ (2006), 보건복지부